Kindred Biosciences, Inc.
(NASDAQ : KIN)

( )
KIN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. -0.30%186.071.9%$326.91m
TEVATeva Pharmaceutical Industries Ltd. 0.39%10.192.0%$75.11m
JAGXJaguar Health, Inc. 0.60%1.680.9%$29.04m
KINKindred Biosciences, Inc. 0.11%9.210.2%$25.38m
RDYDr. Reddy's Laboratories Ltd. -0.50%71.332.0%$7.44m
TXMDTherapeuticsMD, Inc. 0.84%1.2015.3%$5.75m
COCPCocrystal Pharma, Inc. 2.29%1.340.0%$5.06m
ABEOAbeona Therapeutics, Inc. -1.82%1.623.7%$2.10m
TAROTaro Pharmaceutical Industries Ltd. -2.11%71.766.6%$1.98m
CPHIChina Pharma Holdings, Inc. 1.92%0.710.1%$1.18m
LFVNLifeVantage Corp. -2.54%6.903.4%$0.54m

Company Profile

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.